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INTRODUCTION 
Transthoracic direct current countershock causes myocardial 
necrosis in dogs with preservation of normal regional myocardial blood 
flow. Technetium - 99^ stannous pyrophosphate, a myocardial infarct 
imaging agent, depends on blood flow for delivery to tissue. Coiunter- 
shock injury, unlike infarction, should permit myocardial radionuclide 
uptake in direct proportion to the extent of tissue necrosis. 
Experiments were undertaken to validate the quantitative use of 
99m 
Tc stannous pyrophosphate in the countershock model by correlation 
with an independent indicator of myocardial injury, tissue creatine 
phosphokinase depletion. This model was then used to assess the effects 
of pretreatment with methylprednisolone, a corticosteroid which has been 
reported to protect against myocardial infarction. Precordial electro¬ 
cardiographic ST segment mapping and tissue histologic and histochemical 
studies served as additional means of assessing myocardial damage. 
99t^ Further experiments evaluated effects of methylprednisolone on Tc 
stannous pyrophosphate distribution and excretion. 
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REVIEW OF THE LITERATURE 
DC Countershock and Myocardial Injury 
Direct current (DC) countershock was introduced almost 15 years 
ago, supplanting alternating current (AC) defibrillation in the treat¬ 
ment of certain cardiac arrhythmias resistant to drug therapy and 
requiring urgent conversion. DC countershock has rarely been associated 
with hypotension, left ventricular failure, and systemic and pulmonary 
embolism (l, 2), but the most frequent complications in man and in 
experimental animals are transient ventricular rhythm disturbances, 
noted first by Lown and coworkers (3) and since by many others (l, 2, h, 
5, 6). Ventricular premature beats and ventricular tachycardia are the 
most common of these disturbances and occur with greatest frequency in 
patients on digitalis (?), hut ventricular fibrillation (l, h, 7) and 
atrioventricular nodal dysrhythmias (l, , 6) have been reported. There 
is some evidence that DC countershock increases both ventricular auto- 
matlcity and intraventricular conduction time, permitting impulse 
reentry (6). Application of DC shock to cultured chick myocardial 
cells induces diastolic depolarization, a property of pacemakers (T). 
Electrocardiographic ST-T wave changes have occasionally been 
associated with DC countershock. In patient studies there have been 
reports of transient ST segment elevations (l, U) and depressions(l). 
There are reports of minor T wave changes (5) as well as T wave in¬ 
versions persisting over several days (l, 2). In their recent exhaust¬ 
ive analysis of patient reports, Lepeschkin et al. found ST segment 
elevation usually lasting less than two minutes in 2.9% of 2,3^1 
reported cases and inverted T waves usually lasting several days in 
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3.5^ of 1,520 cases (?)• Lown et al. noted that after multiple counter¬ 
shocks, several dogs developed sequential electrocardiographic changes 
characteristic of myocardial infarction (3). 
The possibility of myocardial injury resulting from countershock 
vas suggested by reports of increased serum glutamic oxaloacetic 
transaminase (SGOT) (l, 2, U, 5, 8, 9), lactic dehydrogenase (LDH) (2, 
8) , and creatine phosphokinase (CPK) (lO) in the serum of patients of 
patients after cardioversion. However, Increases in these enzymes were 
never well correlated with electrocardiographic changes thought to 
suggest cardiac damage (l, , 9)* In addition, case reports described 
patients dying after l4o DC countershocks over 3 days (ll) and 3^ DC 
countershocks over I6 hours (l2) yet showing no sign of recent myocardial 
injury at autopsy. Two recent studies have distinguished,chemically 
among isoenzymes of LDH (l3) and CPK (l4) and have explained post¬ 
countershock increases in these enzymes in patients largely on the basis 
of skeletal muscle release and not myocardial necrosis, although two 
cardioverted patients did have modest increases in serum MB CPK, the 
myocardial isoenzyme (l4). It has been shown that multiple countershocks 
can cause pectoral muscle necrosis in man (l5), but release of muscle 
enzymes may occur in the absence of cell death, e.g., in exercise. 
Skeletal muscle damage after coiintershock has consequences for the 
radionuclide assessment of myocardial infarction, as will be described. 
The origin of the experimental use of countershock to produce 
myocardial injury in dogs can be traced to the work of Tedeschi and 
White, who found that AC and condenser discharge countershock applied 
directly to the heart surface produced necrosis of underlying epicar- 
di-um and myocardium (16). Others have carefully characterized the 
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morphologic changes resulting from directly applied or transthoracic 
countershock and have shown that the severity of myocardial damage 
roughly correlates with energy delivered (IT, l8). Dahl et al. have 
demonstrated that the extent and severity of damage after transthoracic 
countershock in dogs varies inversely with both electrode paddle diameter 
and time interval between shocks (19? 20). Importantly, it is known 
that countershock injury spares the myocardial microcirculation. DiCola 
et al. recently showed in this laboratory that myocardium damaged by 
transthoracic countershock in dogs has normal regional myocardial blood 
flow, measured with radioactive microspheres, 2h hours following injury 
(21). This has profound implications for the use of radionuclide uptake 
in assessing countershock damage. 
Modification of Myocardial Injury by Corticosteroids 
Infarct size is thought to be a major determinant of early mor¬ 
tality after myocardial infarction (22). The occurrence of cardiogenic 
shock is related to the area of myocardial injury (23). Myocardial in¬ 
farction occurs by a process of evolving cellular events over a period 
of more than U5 minutes in experimental coronary artery ligation (2h) 
and, perhaps, of several hours in the clinical situation, depending on 
the availability of collateral blood flow. Attempts have been made 
both experimentally and clinically to salvage Ischemic myocardium (25-27). 
One intervention whose value in modifying myocardial necrosis is 
debated is corticosteroid intervention. Corticosteroids are known to 
inhibit wound healing, and impaired myocardial infarct healing after 
corticosteroid administration has been associated with ventricular 
aneurysm formation (28). however, effects of corticosteroids on mem- 
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branes, the inflammatory response, hemodynamics and metabolism suggested 
possible benefit to jeopardized myocardium. In an early study, cortisone 
given in pharmacologic doses to dogs after coronary artery ligation 
decreased infarct size and mortality, despite delayed scar formation (29). 
Other studies did not confirm these observations (30-33). 
More recently, Libby et al. used epicardial electrocardiographic 
ST segment mapping, which correlated with both tissue CPK activity and 
histologic appearance, to demonstrate significant protection by hydro¬ 
cortisone of myocardium from infarction if administered within 6 hours 
of coronary artery occlusion in dogs (3^). Spath and coworkers have 
shown in the cat that methylprednisolone or dexamethasone treatment 
after coronary occlusion reduce ST segment elevation and limit the rise 
in plasma CPK activity (35} 36). On the other hand, Osher et al. demon¬ 
strated a worsening of ST segment abnormality in methylprednisolone- 
treated dogs with acute coronary occlusion (3T). In addition, Vogel 
et al. found no difference in myocardial enzyme depletion or nitro-blue 
tetrazollum dye staining with methylprednisolone administration before 
or after left circumflex artery occlusion in dogs (38). Kraikltpanitch 
et al. found no difference in serum SCOT or CPK with hydrocortisone 
treatment in epinephrine-induced myocardial injury in dogs, but myocardial 
calcium uptake, considered an Indicator of cellular injury, and histo¬ 
logic evidence of necrosis were decreased (39)* 
Two early, uncontrolled clinical studies suggested that administra¬ 
tion of corticosteroid improved survival of patients with severe acute 
myocardial infarction, especially those in cardiogenic shock (Uo, ^l). 
There is evidence of a general salutary effect of corticosteroids on 
the microcirculation in shock (Up), which could improve survival in- 
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dependent of the extent of myocardial damage. A controlled trial in a 
greater niimber of patients found that hydrocortisone did not reduce 
mortality after acute myocardial infarction, even in patients in shock 
(U3). A report on hh6 patients treated vith hydrocortisone 500 mg a 
day for 3 days, a dose larger hut administered for fewer days than in 
previous clinical trials, has indicated that the treated group had a 
lower mortality than did the comparison group of ^91 patients {kh). 
However, these data are difficult to evaluate because the control group 
was cared for by different staffs on different wards, received anti¬ 
coagulant therapy, unlike the hydrocortisone group, and ambulated 
earlier. 
Using serial serum CPK deteimiinations in patients with acute myo¬ 
cardial infarction in order to predict the ultimate extent of infarction, 
two tests of corticosteroid therapy in man have produced conflicting 
results. Morrison et al. found that one or more massive doses of methyl- 
prednisolone administered to 66 patients with acute myocardial infarction 
significantly reduced expected infarct size, predicted by CPK curve¬ 
fitting techniques (U5). Unfortunately, the two patient groups were 
not identical, the treated group actually having more severe infarcts, 
both predicted and completed, than control. In contrast, Roberts et al. 
gave 12 patients multiple dose methylprednisolone over hQ hours after 
acute myocardial infarction and found that completed Infarcts in the 
treated group far exceeded what had been predicted, suggesting an ex¬ 
acerbation of myocardial injury by multiple dose corticosteroid. This 
effect was not seen in 10 patients given single dose methylprednisolone 
{h6). 
Several mechanisms have been proposed whereby corticosteroids 
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the following sections. 
Lysosomal Stahilization 
Lysosomal membrane stabilization is the most cited mechanism by 
which corticosteroids might reduce myocardial cellular necrosis (3^-36). 
DeDuve gave the name "lysosome" to cytoplasmic granules rich in hydro¬ 
lytic enzymes (^7). He showed that ischemia causes release of hydro¬ 
lytic enzymes from rat liver, and commented: "Such a process could 
conceivably play a causal role in cell death, but it could also occur 
as a consequence of this phenomenon which may itself be due to more 
rapid alterations, unrelated to the invasion by lysosomal enzymes." 
(U8). We issman and others have shown that corticosteroids protect 
biomembranes, including lysosomal membranes, from a variety of injuries 
(ii9-52). Corticosteroids are thought to stabilize membranes directly, 
perhaps by restricting movement of phospholipid chains, and also to 
inhibit fusion of lysosomes to the cell membrane (53). 
In myocardial ischemia produced by coronary occlusion or asphyxia 
in dogs, acid phosphatase, glucuronidase and other lysosomal enzymes 
rapidly shift from the particulate or sedimentable to the free or non¬ 
sedimentable state (5^-56). Myocardial cellular pH falls as lactate 
acciomulates during ischemia (57, 58), approaching the acid pH at which 
hydrolytic enzymes are maximally active (59)- It is thus postulated 
that conditions are optimal in the ischemic myocardial cell for de¬ 
gradation of essential macromolecules by free lysosomal enzymes, causing 
cell death. The validity of this postulate has been questioned as a 
result of studies indicating that ventricular myocardium contains few 
"classical" or primary lysosomes (60) and that Irreversible ischemic 
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myocardial injury can occur in the absence of electron microscopic evid¬ 
ence of lysosomal membrane disruption (6l). These results suggested that 
perhaps acid hydrolases recovered by ultrafiltration in the non-sedimen¬ 
table cytoplasmic fraction are released not by cardiac lysosomes but by 
endothelial and Interstitial cell organelles. However, in vitro human 
glial lysosomes have been made to leak acid phosphatase through membranes 
appearing ultrastructurally intact (62). In addition, Hoffstein et al. 
have demonstrated in the myocardial cell that acid hydrolases are in¬ 
timately associated with the sarcoplasmic reticulum, and that two hours 
after coronary occlusion in dogs, there is decreased membrane-bound 
enzyme activity in the endocardium (63, 6h). 
That corticosteroids improve myocardial lysosomal resistance to 
ischemia is indicated by the studies of Spath and coworkers, who found 
that administration of methylprednisolone or dexamethasone before or 
after coronary ligation in the cat prevented or reduced the decline in 
acid hydrolases in ischemic zones and the shift from bound to free state 
(35, 36). Busuttil et al. found less -glucuronidase in coronary sinus 
blood of dogs with ischemic cardiac arrest treated with methylpredniso¬ 
lone than control (65). Hoffstein et al. also showed that methylpred¬ 
nisolone permitted the retention of hydrolytic enzymes by endocardial 
sarcolemma and prevented the redistrubution of enzymes to the non-sedi¬ 
mentable state in dogs with coronary occlusion (64). Finally, Replogle 
et al. noted that 10 patients given intravenous dexamethasone before 
and after cardiopulmonary bypass had lower serum /^-glucuronidase at 4 
hours and a "better general appearance" postoperatively than control (66), 
but it may be unfair to infer that myocardial damage was avoided. 
Two recent reviews express skepticism that corticosteroids could 
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have as their primary action vivo the stabilization of lysosomal mem¬ 
branes (6T, 68). Both articles point out that tissue corticosteroid con- 
-k 
centration would have to approach 10 M, a level higher than it seems 
possible to achieve therapeutically. They also point to the inconsistent 
correlation of steroid chemical structure with biological activity. For 
example, cortisone used vitro is as effective as cortisol, but only 
cortisol is effective in vivo. Lastly, both agree with deDuve (^8) that 
release of lysosomal enzymes may not be the cause of cell death at all. 
Okuda et al. have recently found that the isolated, perfused rat 
heart accumulates trltiated-methylprednisolone and -dexamethasone largely 
in the plasma membrane cell fraction, and that during acute ischemia, 
activity of 5’-nucleotidase, a plasma membrane marker, is preserved in 
corticosteroid-treated hearts compared with control (69). This supports 
the belief that corticosteroids interact with cell membranes, but it 
does not exclude other effects, and it may not apply vivo. 
Anti-inflammatory Effects 
Glucocorticoids are known to alter many aspects of immune and 
inflammatory responsiveness. They are lympholytic, inhibit leukocyte 
adherence to vascular walls, and reduce platelet aggregation, diapedesis 
and cellular Infiltration (68). Systemic corticosteroids are vasocon¬ 
strictive on both normal and Injured capillary beds, and vasoconstric¬ 
tion could decrease extravasation of cells and fluid (68). The inflam¬ 
matory reaction which accompanies myocardial Injury, whether ischemic 
or countershock-produced, may exacerbate tissue Injury. In addition to 
reducing the inflammatory infiltrate, corticosteroids could stabilize 
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Increased Coronary Blood Flov 
Johnson et al. first demonstrated that after chronic administration 
of cortisone to dogs after coronary occlusion, their hearts had more 
prominent vascularity than control animals, determined hy x-ray after 
injection of contrast (29). This apparent improvement in collateral hlood 
supply "was thought to explain their improved survival and smaller in¬ 
farcts. Eckstein was unahle to replicate these results, finding no 
difference in vascular pattern or in interarterlal anastomoses as estim¬ 
ated by clamping coronary inflow and recording perfusion pressure dis- 
tally (33). Recently, several groups have confirmed the original obser¬ 
vation that corticosteroid administration increases coronary blood flow 
(TO-T^). Improvement in coronary blood flow of treated dogs has been 
shown variously to occur in normal (non-ischemic) myocardium (TO), in 
ischemic myocardium (71, 72), in both normal and ischemic myocardium (7^), 
and in ischemic but not in normal myocardium (73). It has been theorized 
that corticosteroid administration might enhance the "Ischemic stimulus" 
to opening of collateral vessels (73). It should be noted here that 
since countershock myocardial inj'ury is non-ischemic, it seems unlikely 
that an increase in coronary blood flow would modify necrosis. 
Hemodynamic Effects 
A number of studies have indicated that corticosteroids have a 
positive inotropic effect, increasing- or averting a decrease in -the 
maximal rate of rise of left ventricular pressure (LV dP/dt) (65, 70-72, 
7^-76). Other investigators have been unable to demonstrate an increase 
in LV dP/dt after corticosteroid traetment in acute Ischemia (37, 
73). Da Luz et al. recently showed that dogs treated with methylpredni- 
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ischemic segment, indicating-better regional myocardial function, than 
control after three hours of ischemia, and also after one hour reper¬ 
fusion (TT). Tecklenberg et al. found that the transient positive ino¬ 
tropic response to corticosteroids vas augmented by cardiac denervation 
in the dog, and reduced by i^-adrenergic blockade with propranolol or by 
acute adrenalectomy; they suggest that corticosteroids release and/or 
potentiate endogenous catecholamines, which then mediate the positive 
inotropic effect (T6). 
Another line of evidence indicates that the inotropic state of rat 
myocardium is regulated by the cyclic nucleotides, cAMP and cGMP, and 
that increases in myocardial cGMP are associated with reduced contrac¬ 
tility (78). Infarcted canine myocardiiim contains reduced levels of 
C.AMP and increased cGMP (79)- Adrenalectomy increases cGMP in rat 
skeletal muscle, an effect reversed by dexamethasone (80). Butsuttil 
et al. found that methylprednisolone pretreatment reduced the elevation 
of left ventricular myocardial cGMP produced by Ischemic cardiac arrest 
in dogs; this was associated with a preservation of LV dP/dt (65). 
A positive inotropic effect of corticosteroids could potentially 
provide either help or hindrance to Ischemic myocardium. Inasmuch as 
increases in the contractile state of the myocardium increase oxygen 
demand, hypoxic tissue would face further jeopardy. Maroko et al. 
have shown that other interventions with positive inotropic effects 
increase the extent of ischemic injury after coronary occlusion in dogs 
(25, 81). However, in the event of pump failure, an inotropic stimulus 
might be life-saving. 
Other hemodynamic determinants of myocardial oxygen demand may be 
influenced by corticosteroids. Left ventricular end diastolic pressure. 
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or preload, is a determinant of intramyocardial tension, and has been 
found both to decrease (TO, 71, T6) and not to change significantly (37, 
74). Arterial or left ventricular pressure has been shown to fall tran¬ 
siently soon after corticosteroid administration (34, 37,42, 71, 73, 82), 
perhaps because of a direct vascular effect with fall in systemic vas¬ 
cular resistance (76), and one group has invoked this as a potential 
means of myocardial salvage. Heart rate after corticosteroid adminis¬ 
tration has increased (37, 83), decreased (7l), or remained unchanged 
(34, 73, 77)• Cardiac index has increased (42, 71), or changed insig¬ 
nificantly (84). Cardiac output has not changed, either in dogs with 
closed chest coronary occlusions (37), or in patients with septic shock 
(85). 
Metabolic Effects 
The metabolic consequences of acute myocardial ischemia have been 
well characterized (86, 87). Aerobic metabolism requires oxygen, and 
there is evidence that corticosteroid administration increases oxygen 
delivery to and uptake by normal (70) and ischemic (71, 73) myocardium. 
Glucocorticoid may additionally decrease myocardial oxygen consumption 
(88) and shift the oxyhemoglobin dissociation curve to the right, pro¬ 
moting oxygen release (89). Busuttil et al. found that dogs treated with 
methylprednisolone had a greater arterial p02 than control during recov¬ 
ery from ischemic cardiac arrest (65), and Motsay et al. found that cor¬ 
ticosteroid-treated dogs with coronary occlusions and patients in 
cardiogenic shock cons\mied more oxygen than those untreated, perhaps 
because of a non-specific Improvement in viscerocutaneous perfusion 
(42). 
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Reduced oxygen supply to the myocardium causes shift in cellular 
oxidation-reduction state so that the reduced form of nicotinamide 
adenine dinucleotide (NADH) predominates over the oxidized form (NAD). 
Shifts in cytoplasmic NAD:NADH ratios are grossly reflected by shifts 
in intracellular lactate:pyruvate ratios, indicating shifts from 
aerobic to anaerobic metabolism. Myocardial Ischemia has been ex¬ 
pressed in terms of lactate extraction and production, but many var¬ 
iables modify such measurements, including the requirement for "washout" 
of intracellular lactate into the venous drainage which is sampled (90). 
Brachfeld and Da Luz et al. (TT) have both demonstrated improved lactate 
balance in ischemic myocardium with corticosteroid treatment, suggesting 
reduced anaerobic metabolism and increased tissue viability. On the 
other hand, others have been unable to show a significant difference in 
lactate balance (375 65). Yet others have found increased lactate in 
coronary sinus blood with corticosteroid treatment in myocardial ischemia, 
and explain this as a consequence of improved coronary blood flow and 
enhanced "washout" (73, 84). 
Masters et al. have shown that Ischemic myocardium has increased 
uptake of glucose, and decreased uptake of pyruvate, lactate and free 
fatty acids, reflecting transport gradients resulting from anaerobic met¬ 
abolism. Methylprednisolone Increased free fatty acid and lactate 
uptake, and markedly increased pyruvate production (73). Increased 
production of pyruvate, an essential substrate for anaerobic metabolism, 
may be due to the known enhancement of gluconeogenesis by glucocorticoid. 
Corticosteroids have also been shown to increase serum glucose in man 
(83) and dog (76) and to accelerate glucose turnover in the dog (92). 
Myocardial potassium balance has been used as an Indicator of 
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cellular Integrity during ischemia, and there is evidence "both for 
improvement (65, TT) and for no change (37) as a result of cortico¬ 
steroid administration. 
Assessment of Myocardial Injury by ^^^c-PYP 
Technetium-99ni stannous pyrophosphate (^^^c-PYP) is a well known 
bone scanning agent which has recently been established by Willerson 
and colleagues as a clinical tool useful in the detection of acute 
myocardial infarction in man (93, 9^) and as a research tool permitting 
evaluation of experimental infarction in the dog (95)* ^^™Tc-PYP 
myocardial scintigrams become positive 12 to 16 hours after coronary 
artery ligation or clinical onset of infarction, increase in intensity 
over the next 12 to 36 hours, remain positive up to 6 days after the on¬ 
set of infarction and then fade, usually becoming negative by the lUth 
day after coronary occlusion in dogs and within 7 days after the onset 
of infarction in patients (93-95)- The mechanism by which ^^™Tc-PYP 
accumulates in infarcted myocardium is believed by Buja et al. to in¬ 
volve binding to abnormal calcium deposits in the mitochondria of dead 
cells (96, 97)- Mitochondrial calcium uptake accompanies irreversible 
cellular injury, and is postulated to be a common pathogenic mechanism 
for muscle necrosis (98). Fleckenstein hypothesizes that calcium uptake 
impairs cellular phosphorylatlng capacity and adenosine triphosphate (ATP) 
synthesis, resulting in cell death (99)- In dogs with experimental 
infarcts, ^^™Tc-PYP myocardial uptake has been noted to occur at about 
the same time (at 1-2 days, disappearing between 7 and 13 days) and in 
approximately the same location (in ’’peripheral zones” of infarction) 
as myofibrillar calcification, ultrastructurally resembling hydroxy- 
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apatite crystals within mitochondria (96). Suhcellular distribution 
45 
studies by Dewanjee and Kahn in the rabbit indicate that Ca and 
99^= ~PYP taken up by infarcted tissue are associated mainly with the 
soluble protein fraction, not the mitochondrial fraction; they postulate 
that ^^™Tc-PYP binds with denatured cellular macromolecules to form 
polynuclear complexes- independent of cellular calcium uptake (lOO). 
Incubation of fetal mouse hearts in calciiim-free culture medium does 
not reduce ^^™Tc-PYP uptake after metabolic injury (lOl). 
Attempts have been made to use ^^^c-PYP scanning and tissue assay 
to quantify infarct size in clinical and experimental situations. The 
size of experimental anterior wall infarcts has been estimated with some 
success from the scintigraphic ^^™Tc-PYP "hot spot" area, which correlates 
with infarct weight (l02, 103). Difficulties have been encountered in 
attempts to evaluate the extent of infarction in terms of the intensity, 
or count density, of the radionuclide scan. Positive myocardial scans 
after proximal left anterior descending coronary artery occlusion in dogs 
typically show "doughnut" patterns, with marked peripheral concentration 
of radioactivity surrounding central zones of much lower activity (96, 
lOU). Studies using experimental Infarcts in dogs have shown by direct 
tissue assay that myocardial uptake of ^^™Tc-PYP does not correlate well 
with either tissue CPK depletion (105) or the histologic extent of 
necrosis (lOU, I06). The reason for this has been established by corre¬ 
lation of ^^™Tc-PYP myocardial uptake with regional myocardial blood 
flow, estimated by tissue distribution of radioactive microspheres (105- 
108). Zaret et al. found that in experimental Infarction, ^^™Tc-PYP is 
taken up maximally by tissue with 30-40^ of normal blood flow, and pro¬ 
gressively less with greater degrees of Ischemia (105). This indicates 
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that accumulation of tracer in necrotic myocardium requires delivery to 
the site of necrosis. The characteristic "doughnut" scan image results 
from blood flow in the center of the infarct inadequate to permit 
delivery of tracer. Thus, ^^™Tc-PYP distributes unevenly in myocardial 
infarcts. This limits quantification of the extent of necrosis to 
measuring the area of the scintiscan "hot spot" (102, 103). 
An additional problem is that the scan image is a two dimensional 
representation of a three dimensional object (109, llO); thus, activity 
in tissues above and belou the area of interest are superimposed, re¬ 
ducing contrast, and gamma radiation is attenuated as it passes through 
tissue between the area of interest and the detector. This problem is 
only in part alleviated by scanning in several positions. Another 
apparent limitation to the quantitative use of ^^™Tc-PYP scanning is 
its lack of complete specificity. Some patients with unstable angina 
pectoris and, occasionally, patients -with simple angina pectoris have 
been found to have diffusely positive ^^™Tc-PYP scans, apparently un¬ 
related to the severity of their coronary artery disease, determined 
angiographically (111-113). It has been suggested that tracer may 
sequester in ischemic myocardium, but the presence of necrotic foci 
amidst otherwise reversibly injured tissue has not been ruled out. 
Positive myocardial scans have been reported in patients with 
left ventricular aneurysm (llU) and in dogs after experimental cardiac 
contusion (II5). Pugh et al. have shown that there is abnormal uptake 
of ^^™Tc-PYP in pectoral muscle of dogs 2k hours after transthoracic 
countershock (II6). After cardioversion, several patients have report¬ 
edly shown sites of ^^^c-PYP accumulation on scans not corresponding 
to electrographic localization of myocardial Infarction; it is felt that 
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these "false positive" myocardial scans represent radionuclide uptake 
in damaged skeletal muscle (llT). 
DiCola et al. have shown in the dog that myocardium damaged hy 
high energy transthoracic countershock accumulates ^^^c-PYP in amounts 
far greater than ischemic infarcts (2l). Abnormal radionuclide uptake 
was subepicardial to full thickness, corresponding to the depth of tissue 
necrosis, demonstrated histologically and histochemically. At the 
same time, regional myocardial blood flow, measured with radioactive 
microspheres 2h hours following countershock, was maintained (2l). Be¬ 
cause countershock injury is non-ischemic, myocardial uptake of ^^^c-PYP 
should correlate directly with the extent of necrosis, and permit quan¬ 
titative evaluation of myocardial damage. This provided impetus for 
the experiments to be described. 
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Effects of Methylprednisolone on Countershock Injury 
Twenty-five mongrel dogs of either sex ranging in weight from 
12.3 to 19.5 kg were anesthetized with intravenous sodium pentobar¬ 
bital, 30 mg/kg, intubated and placed on a Harvard respirator. Twelve 
of the dogs were given methylprednisolone sodium succinate (Solu-Medrol, 
Upjohn), 30 mg/kg, as an IV bolus, and a weight-matched group of 13 
dogs received an equivalent volume of its vehicle. Ninety minutes later 
with each dog lying in the left anterior oblique position, h cm diam¬ 
eter paddle electrodes were applied with electrode paste (Redux Paste, 
Hewlett Packard) at the points of maximal cardiac impulse on the shaved 
left and right chest, and two UOO watt-second electroshocks (320 watt- 
seconds delivered across a 50 ohm resistance) separated by one minute 
were administered via a B-D Electrodyne Model ELD-5B DC pulse external 
defibrillator. Animals were medicated with lidocaine 100 mg IV two 
minutes before shock and as necessary afterward to eliminate ventricular 
ectopy. Electrocardiographic recordings were made before countershock, 
and 5 minutes and 60 minutes after, with a precordial electrode placed 
successively at 15 points mapped out in advance in three rows of 5 
points in the left Uth, 5th and 6th intercostal spaces, from sternum to 
to left mid-axillary line. 
Twenty-four hours following countershock, dogs were again anesthe¬ 
tized, then injected with approximately 10 milllcurles of ^^™Tc-stannous 
pyrophosphate (Malllnckrodt). Each dose was measured precisely in a 
RadX dose calibrator. One hour later, animals were sacrificed with 
IV potassium chloride, and hearts were removed, trimmed of epicardial 
fat, and cut into approximately 25 1-2 gm transmural samples, including 
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all grossly abnormal tissue with wide border zones, and 5 normal samples 
from the posterior left ventricle. Samples were divided into epicardial 
and endocardial halves, weighed and counted for ^^™Tc activity in a Picker 
Spectroscaler III A well-type scintillation counter with a 3" x 3" 
sodium iodide crystal at a window of lOO-lUo keV. Sample radioactivity 
was calculated as counts per minute per gram of tissue per millicurie 
injected, and was correctedfor decay of ^^c (half -life = 6.0 hours) 
from the exact time of sacrifice of the animal. 
Before dissection, T hearts from each group were quantitatively 
Imaged using a computerized multicrystal scintillation camera (Baird- 
Atomic System 77). Great vessels and atria were removed, and ventricles 
were scanned for l6 minutes with the anterior epicardial surface 5 cm 
from the 2" high-resolution, parallel hole collimator. Data were stored 
on magnetic tape after uniformity flood and environmental background 
correction. Cardiac scan images consistently demonstrated two zones of 
increased ^^™Tc-PYP uptake, one in the area of the right ventricle and 
one near the apex of the left ventricle, as well as low background 
cardiac activity (Figure la.). Computerized data processing of each 
abnormal scan involved, first, increasing the minimal count level 
displayed as non-zero data to the extent judged necessary for elimination 
of background activity. Each abnormal zone was then divided by Itself 
to obtain a unity image (Figure lb.), defining the "hot spot" in terms 
2 
of numbers of detector crystals, each 7-73 mm . The original, back- 
ground-corrected scan was then divided by the unity image, giving the 
number of counts in the abnormal zone. This peimiitted expression of 
abnormal zone activity in terms of accumulated counts/cm . 
In 5 hearts from control and U from methylprednisolone-treated (MP) 
dogs, h0-80 mg full-thickness portions of each tissue sample were assayed 
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for creatine phosphokinase (CPK). These samples were immediately 
frozen in liquid nitrogen, homogenized in 2 ml of 0.01 M phosphate 
buffer (pH 7*2) containing 0.01 M sodium EDTA, 0.01 Trls HCl and 0.01 
M glutathione, and centrifuged at 10,000 RPM for ten minutes. One 
ml of the supernatant was used for measurement of CPK by the method of 
Rosalki (ll8). 
Transmural biopsies were taken for histopathologic study from 
the centers of abnormal zones in 8 control and 8 MP dogs. These were 
fixed in 10^ formalin, embedded in paraffin, cut, and stained with 
hematoxylin and eosin, Masson trichrome and hematoxylin basic fuchsin 
picric acid stains (ll9). Sections were examined for evidence of necro¬ 
sis, hemorrhage, edema and cellular reaction, and for depth of myocardial 
injury. 
Thirteen biopsies from each group were graded semiquantitatively as: 
0, no definite necrosis; 1+, scattered, mild, but definite necrosis; 2+, 
subepicardial necrosis (limited to outer 1/2 of myocardium) with moderate 
to severe tissue reaction; 3+, transmural necrosis (greater than 1/2 
full-thickness) with moderate to severe tissue reaction. 
Effects of Methylprednisolone on ^^^c-PYP Distribution and Excretion 
The effects of methylprednisolone on the distribution in blood 
and bone and on the clearance and excretion of ^^™Tc-PYP were studied 
by the following protocol. Thirty-four dogs were divided into IT 
weight matched pairs. One dog of each pair received methylprednisolone, 
30 mg/kg IV, and the other its vehicle 2'k hours prior to injection of 
about 10 millicuries ^^^c-PYP. Animals were always studied simultan¬ 
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catheterized and emptied by external massage just prior to injection of 
^^™Tc-PYP. The bladder was emptied at 10 minute intervals thereafter 
until sacrifice, at which time the abdomen was entered and the bladder 
emptied of residual urine. The volume of each sample was recorded, 
and a 2 ml aliquot was saved for well-counting. Two ml samples of ar-^ 
terial blood were withdrawn through a femoral artery catheter before PYP 
Injection, and at 1, 2, 5? 10, 20, 30, Uo, 50 and 60 minutes after 
injection, and saved for well-counting. Twelve dogs (6 |)'airs) studied 
earlier had fewer arterial blood samples and no urine collected, a point 
clarified in Tables U and 6. Animals were sacrificed with IV potassium 
chloride at 60 minutes. 
Plasma was separated by centrifugation from arterial blood drawn 
at the time of sacrifice from 5 pairs of dogs. Separation of plasma 
protein was then accomplished by a modification of the method of Somogyl 
(13^). 0.5 nil plasma, 3.5 ml H^O and 0.5 ml zinc sulfate reagent (lOO 
gm ZnSO^* TH^O and Uo ml 6.25N H^SOj^ diluted to 1000 ml with H^O) were 
mixed, and 0.5 ml of 0.T5N sodium hydroxide was added dropwise. The sol 
ution was stirred for 20 minutes and centrifuged 10 minutes, the super¬ 
natant was discarded, the precipitate was resuspended in distilled H^O 
and recentrifuged, and the precipitate was saved for ^^™Tc well-counting 
In 6 pairs of dogs, three 2-3 gm cortical bone samples were taken 
from the right and left Uth ribs, posterior iliac crests and femoral 
heads. As in the countershock studies, 5 1-2 gm normal left ventricular 
myocardial samples were taken from all dogs studied. All tissue samples 
were weighed and counted for ^^™Tc activity. At the same time a 0.1 ml 
aliquot from the same batch of ^^^c-PYP as the injected dose was di¬ 
luted 1:1000 and counted each experimental day to permit calibration of 
-21- 
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the well-counter for CPM per mCl. This permitted expression of ^^™Tc- 
PYP kinetic data in terms of % injected dose per gram of tissue, or per 
volume of excreted urine. 
Ninety minutes before radionuclide injection in 6 pairs of dogs, an 
intravenous infusion of 5^ dextrose in water (D5W) was begun at a rate 
of 300 ml per hour and continued throughout the experiment. In 5 pairs, 
to be assured of adequate urine output, U50 cc D5W per hour were infused 
beginning 90 minutes before PYP injection; also, to facilitate measure¬ 
ment of creatinine clearance, creatinine, 20 mg/kg in 20 cc D5W»'■^'9'® 
administered as an IV bolus, and then infused at 6 mg per minute in the 
D5W drip. One ml aliquots of urine collected at 10 minute intervals 
and of plasma separated by centrifugation from arterial blood drawn at 
20 minute intervals were frozen and saved for creatinine determination 
utilizing a Technicon autoanalyzer. Plasma sodium concentration was 
measured in these 5 pairs of animals before PYP injection and at the time 
of sacrifice (60 minutes) with the Instrumentation Laboratory Flame 
Photometer IU3. 
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RESULTS 
Validation of Tc-PYP Assessment of Countershock Injury 
The validity of utilizing myocardial ^^^c-PYP uptake as an index 
of myocardial necrosis in the countershock model was examined by com¬ 
parison with an independent index of necrosis, tissue creatine phospho- 
kinase (CPK) depletion. Fifty transmural samples from grossly ab¬ 
normal as well as apparently normal border zones in three control animals 
were analyzed. PYP and CPK activity were expressed in the usual way (lOU- 
108) as an activity ratio between each myocardial sam;^le and the mean of 
5 normal samples from the posterior left ventricle - the sample:normal 
ratio (S:W ratio). In the non-ischemic countershock model, as shown in 
Figure 2, PYP S:N ratios, plotted on the ordinate, correlated Inversely 
with tissue CPK S:N ratios, on the abscissa, with r = -0.83. In other 
words, tissue PYP uptake 2h hours following countershock correlates well 
with tissue CPK depletion. 
Effects of ]yiP on Countershock Injury: ^^Tc-PYP Assessment (Table l) 
The 13 control and 12 methylprednlsolone-treated (MP) dogs did 
not differ significantly in weight. For each animal, an average PYP 
sampleinormal ratio was obtained by computing the average of its 5 trans¬ 
mural myocardial samples with the greatest abnormality in S:N ratio. 
The MP group had a significantly greater mean average PYP S;N ratio than 
control, Hl.Ui 6.5 vs. 27.0- 2.2, mean ^ SEM, p<0.05 by group t test. 
This difference is demonstrated graphically in Figure 3, left panel, and 
might lead one to conclude that the methylprednisolone-treated group had 
greater necrosis than control. However, when one looks at absolute 
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TABLE 1 'c~PYP Assessment of Countershock Injury 
Animal Weight Sample:N1 Abnormal Normal Abnormal Abnormal 
(kg) Ratio Zone 
X 10 
Zone'Weight Image Activity 
(counts/cm x 1C (CPM/g/mCi (g) 
CONTROL 
a 19.5 26.5 205.8 7.8 l7.8 
h 18.6 27.3 362.7 13.2 i7.7 
c 19.1 25.7 266.1 10.3 15.0 
d 16.8 2h.h 578.5 23.7 10.8 
e 18.2 4I+.5 519.5 11.7 16.7 
f 16.8 20. h 206.7 10.2 12.3 
g 18.0 33.0 110.0 3.7 7.0 6.78 
h 16.8 32.5 ; 91.3 2.8 8.3 7.96 
i 18.2 16.1 65.7 7.1 3.9 7.09 
j 15.9 22.9 102.8 7.5 9.3 3.30 
k 17.3 lk.9 151.1 10.1 6.1 2.65 
1 17.3 28.5 118.8 7.1 7.1 5.76 
m 15.5 33.7 211.9 6.3 13.3 5.76 
Mean 17.5 27.0 230.0 8.6 10.7 5.19 
SEM 0.3 2.2 75.7 1.6 1.2 0.73 
METHYLPREDNISOLONE 
A 18.6 13.5 126.6 9.3 12.6 
B 17.5 26.9 216.5 8.0 8.7 
C 17.7 38.0 27i.1 6.7 20.6 
D 17.3 12.2 58.6 7.8 3.7 
E 17.3 38.3 296.8 7.7 10.2 
F 18.2 70.1 87.5 1.2 10.3 5.17 
G 17.3 U0.2 -73.6 1.1 11.3 3.16 
H 17.7 65.^ 88.2 1.7 10.8 5.32 
I 18.2 77.9 93.9 1.3 7.5 6. o7 
J 15.5 29.2 70.9 2.7 9.2 2.78 
K 12.3 25.2 106.7 7.3 9.7 3.31 
L 13.6 60.^4 376.1 5.7 9.7 8.60 
Mean 16.8 kl.h i77.8 7.5 10.3 7.91 
SEM 0.6 6.5 29.2 0.9 1.1 0.78 














abnormal zone activity, expressed in CPM/g/mCi, again by using the 
average of each animal's 5 most radioactive samples, one finds no 
significant difference and, in fact, the control group's mean is 
higher.. (Figure 3, center). Normal zone absolute PYP activity was, 
on the other hand, significantly less in the MP group, p<0.025 (Figure 
3, right). Thus, the increased abnormality of the sample:normal ratio 
in MP dogs appears to be a function of reduced normal zone activity, 
rather than expected Increase in abnormal zone activity. Further data 
corroborating this Interpretation will be presented. 
Abnormal myocardial Tc-PYP uptake was consistently transmural, 
though more epicardlal than endocardial in distribution. An estimate 
of abnormal zone weight was made by summing the weights of all epicar- 
dial and endocardial tissue samples with abnormal 99y c-PYP accumu¬ 
lation, defined as an S:N ratio greater than 3:1. Mean abnormal zone 
weights derived in this way were almost identical, with control, 10.U 
1.2 grams, vs. MP, 10.3 ji 1.1 grams (Table 1, Figure h). 
Cardiac scan Images consistently demonstrated two zones of rather 
uniformly abnormal radionuclide uptake, one in the area of the right 
ventricle and one near the left ventricular apex (Figure la.). PYP 
count densities derived by computerized data processing were equivalent 
in the two groups (Table 1, Figure k). 
Effects of MP on Countershock Injury; CPK Assessment (Table 2) 
The 5 control and ^ methylprednisolone-treated animals for which 
CPK data were obtained did not differ significantly in weight. For 
each dog, an average CPK sample:normal ratio was calculated as for PYP 
by computing the average of its 5 tissue samples with the greatest 
abnormality in S:N ratio. (in this case, abnormality Implies a fall 
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0.13 152 1132 
0.12 146 1196 
0.42 523 1250 
0.27 109 393 
0.11 127 1179 
0.21 211 1030 
0.06 78 160 
0.16 213 1330 
0.19 321 1665 
0.24 254 1058 
0.38 103 270 
0.24 223 1080 
0.05 46 297 
NS NS NS 
SEM 
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in S:N ratio;, indicating CPK depletion.) Figure 5 shovs graphically 
that there were no differences between the two groups in mean CPK S:N 
ratio, which was .21- .06 in the control group vs .2U- .05 in the 
MP group, mean - SEM; nor were there differences in absolute tissue 
CPK, expressed in mlU/mg, in abnormal zones or normal zones. 
Effects of MP on Countershock Injury: Precordial ST Segment Mapping 
ST segment amplitude was measured in all recordings at 0.08 seconds 
after the onset of the QRS complex with the PR segment as baseline (l9)- 
The sum of all ST amplitudes exceeding 2 mm (S(ST) and the number of lead 
positions with such ST elevation (NST) were calculated. There were no 
significant differences between the two groups in either £ST or NST be¬ 
fore countershock (time O) or at 5 minutes or 60 minutes afterward 
(Figure 6). There were several animals in both groups which had slight 
or absent ST segment elevation, yet substantial myocardial necrosis, de¬ 
monstrated histologically and by ^^™Tc-PYP uptake. This accounts for 
relatively large standard errors. ST data are included for one control 
animal for which PYP data are not available because the animal died sev¬ 
eral hours after countershock. 
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Effects of MP on Countershock Injury; Histopathologic Assessment 
On gross inspection, zones of injury vere apparent as pale yellow 
discoloration of epicardium and underlying myocardium, often extending 
transmurally to the endocardial surface. There were consistently two 
distinct, circular areas of right ventricular and left ventricular 
damage, corresponding to "entrance" and "exit" wounds. All abnormal zones 
studied histologically and histochemically showed qualitatively similar 
transmural disruption of muscle fibers, coagulation necrosis, inter¬ 
stitial edema, hemorrhage and mixed cellular infiltration, with mono¬ 
nuclear leucocytes predominating over polymorphs (Figure 7). There 
was no clear difference in mean histopathologic grade between the two 
groups (Figure 7). 
Effects of MP on ^^™Tc-PYP Distribution 
Arterial blood ^^™Tc-PYP activity is presented in Table 3 for 
control and methylprednisolone-treated animals at all times sampled, 
and clearance curves derived from these data are plotted in Figure 8. 
There is no statistically significant difference (group t test) in mean 
blood PYP activity between the two groups at any time shown. Yet, at 
each time between 10 and 60 minutes after Injection, blood PYP activity 
in the MP group is slightly less than control. That this finding is not 
more impressive may be a result of another apparent effect of MP treat¬ 
ment, a dramatic increase in urine volume, 282.1 76.0 (MP) vs. 62.8 
^2^.4 (control) milliliters in one hour, p<0.005 (Table 7)- A large 
water load was given to all but 6 pairs of animals to facilitate measure¬ 
ment of creatinine and PYP clearance, and the increased urine output 
may reflect improved ability to excrete a water load in the MP group, as 
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T 22.4 18.7 
8 49.0 34.1 
9 24.8 22.5 
10 25.6 l6.6 
11 i8.9 12.1 
12 i6.9 11.1 
13 24.4 17.8 
lU 22.3 15.9 
15 22.0 16.0 
l6 18.5 13.9 
IT 22.6 15.9 
Mean 24.3 17.7 
SEM 2.6 1.9 
^Dose/L 38.5 28.1 
^Dose/Tot 55.6 4o.5 
Blood Vol 
5 10 20 30 
8.8 
16.0 11.9 9.7 
12.0 7.8 5.5 
12.4 8.9 5.9 4.7 
19.9 13.7 9.1 7.1 
13.8 8.2 5.3 3.8 
10.2 7.2 4.5 3.1 
7.4 4.9 3.1 2.3 
6.5 4.4 2.9 2.1 
11.2 7.9 5.3 4.3 
10.0 7.1 4.8 3.6 
11.4 7.0 4.7 3.5 
9.1 6.2 4.1 3.1 
9.7 6.8 4.6 3.5 
11.1 8.5 5.9 4.3 
1.1 0.9 0.7 0.6 
17.6 13.5 9.4 6.8 
25.3 19.4 13.5 9.8 








5.2 4.8 3.5* 
3.7 3.1 2.9* 
4.8 4.5 3.8 
3.1 2.5 2.1 
2.7 2.3 2.0* 
1.9 1.6 1.4* 
1.6 1.4 1.2 
3.3 2.7 2.5 
2.8 2.3 1.9 
2.8 2.3 2.0 
2.5 2.1 1.8 
2.9 2.4 2.1 
3.7 3.0 2.8 3.3** 
0.5 0.4 0.3 0.5 
5.9 4.8 4.4 5.2 








7 25.0 18.2 12.0 
8 33.4 25.6 18.1 
9 38.9 22.6 11.6 
10 21.8 14.3 9.2 
11 23.1 15.0 9.0 
12 19.2 13.4 '8.7 
13 25.6 18.0 11.6 
l4 23.9 18.6 12.6 
15 15.6 11.6 7.9 
16 17.7 13.0 8.5 
17 17.6 13.1 8.1 
Mean 23.8 16.7 10.7 
SEM 2.1 1.3 0.9 
NS NS NS 
^Dose/L 37.7 26.5 17.0 







6.5 4.1 3.3 2.3 1.8 
7.5 4.6 3.0 2.5 1.9 
11.9 9.0 6.8 5.0 4.1 
9.1 5.1 3.8 3.1 2.4 
6.9 4.6 3.6 2.8 2.3 
6.0 3.5 2.6 2.0 1.8 
6.0 3.7 2.7 2.1 1.7 
7.8 4.9 3.5 2.9 2.4 
9.7 7.1 6.0 5.6 4.9 
5.4 3.2 2.2 1.8 1.3 
6.2 4.2 3.4 2.9 2.4 
5.5 3.3 2.3 1.9 1.5 
7.4 5.0 3.7 3.2 2.5 
0.5 0.4 0.3 0.3 0.3 
NS NS NS NS NS 
11.7 7.9 5.9 5.1 4.4 



























* ^0 minute -PYP activities of pairs of animals not -water-loaded, 
or with similar urine output. 
** Means for these 60 minute activities, p< 0.025. 

vill be discussed. In theory, the MP dogs had less expansion of their 
vascular voliime by the administered water load. This would have raised 
the concentration of all circulating substances, including PYP, relative 
to the control group, potentially masking a blood PYP-lowering effect 
of methylprednisolone. Supporting this is the fact that measurement of 
sodium concentration by flame photometry in plasma drawn from 5 pairs 
of water-loaded animals before PYP injection (time O) and at the time 
of sacrifice (60 minutes) revealed a significantly smaller drop in plasma 
sodium in the MP group, p<0.025, whether expressed as mean absolute 
change or mean fractional change in sodium concentration (Table 4). In 
addition, if one considers blood PYP activity only in pairs of animals 
not water loaded (control and MP, dogs 1-6) or, if water loaded, with 
similar urine output (control and MP dogs J, 10 and ll), as noted by as¬ 
terisks in Table 3, one finds a statistically significant reduction in 
blood PYP, p<0.025, in the methylprednisolone-treated group at 60 minutes 
after PYP injection. 
Data are presented in Table 5 giving distribution of PYP 60 minutes 
after injection in whole blood, plasma, bone, and myocardium. Mean 
dog weights were the same in the two groups. Whole blood and plasma 
PYP activity are not statistically different, presumably for the 
reasons just cited. Plasma protein-binding, measured in 5 pairs of 
animals, did not differ between the two groups, nor was there a difference 
in bone PYP uptake, determined in 6 pairs of animals. Myocardial PYP up¬ 
take was less in the methylprednisolone-treated group than control, as 
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TABLE 4 Plasma Sodium in Water-Loaded Animals 
(mEq/L) A 




13 130.2 128.2 2.0 0.015 
Ik 139.3 129.8 9.5 0.068 
15 132.8 126.3 6.5 0.049 
l6 138.0 133.9 4.1 0.030 
IT 130.0 123.6 6.4 0.049 
Mean 13k.1 128. U 5.7 0.042 
SEM 1.9 1.7 1.3 0.009 
METHYLPREDNISOLONE 
13 127.8 124.8 3.0 0.023 
ih 130.8 129.0 1.8 0.014 
15 136.5 134.3 2.2 0.016 
l6 136.0 132.6 3.4 0.025 
17 133.1 130.4 2.7 0.020 
Mean 132.8 130.2 2.6 0.020 
SEM 1.6 1.6 0.3 0.002 
NS NS p<0.025 p<0.025 
t 
' /iiOtJ-'X5 '^s’w j-J; ffn./', 





1 ■ l' , ■ 
r - - 
’. 








■ . T 




' .s: £ ni-f^ 
fO... 
>1 








(kg) (CPM/ml/mCi : X 10"^) dose/g) (CPM/g/mCi X 10 ■^) 
CONTROL 
1 18.2 3.98 11.7 
2 16.8 6.57 23.7 
3 19.1 3.^8 10.3 
1| 13.6 U.28 12.3 
5 16.8 1.95 4.8 
6 19.5 3.36 7.9 
7 23.2 2.93 4.57 0.023 7.7 
8 10.0 3.78 5.55 0.033 10.7 
9 19.1 2.08 2.77 0.0l4 13.4 
10 2U.5 2.01 3.21 0.013 5.1 
11 25.5 l.hh 2.28 0.007 3.6 
12 21. U 1.23 1.68 0.019 3.6 
13 16. 2.57 3.45 3.02 6.8 
II4 18.2 1.93 2.83 2.26 5.1 
15 24.1 1.97 2.75 2.28 5.5 
16 23.6 1.81+ 2.63 2.17 5.1 
IT 17.3 2.07 2.92 2.46 5.2 
Mean 19.2 2.79 3.15 2.44 0.018 7.4 
SEM 0.8 0.33 0.32 0.15 0.004 1.1 
(77.5^) 
k.k2 % dose/L 0.00118 % dose/g 
6.36 % dose/Tot Blood Vol 
METHYLPREDNISOLONE 
1 17.3 3.75 7.7 
2 17.3 2.81+ 4.8 
3 17.7 1.51 6.4 
4 9.1 1.1+4 l4.6 
5 18.2 1.45 3.1 
6 20.5 2.65 6.0 
7 22.7 1.87 2.76 0.015 3.6 
8 lU.i 3.38 4.69 0.032 8.1 
9 18.2 2.30 3.14 0.015 4.4 
10 26.h 2.04 3.07 0.012 5.0 
11 25.5 1.42 2.14 0.012 3.2 
12 22.3 1.32 1.88 0.018 3.6 
13 16 ,.8 2.13 3.12 2.4i 5.9 
1^+ 1^.5 4.49 6.85 4.66 9.1 
15 26.U 1.20 1.61 1.44 3.1 
16 22.3 2.24 3.27 2.35 5.0 
17 20.5 1.30 1.69 1.39 3.1 
Mean 19.^ 2.20 3.11 2.45 0.017 5.0 
SEM 0.9 0.23 0.46 0.59 0.003 0.7 
(78.8^) 
3.49 ^ dose/L 0.00079 % dose/g 
5.06 ^ dose/Tot Blood Vol 















;f-r ' ■ of 
, ‘i 
Effects of MP on ^^™Tc-PYP Excretion 
An explanation for reduced blood and tissue PYP levels in the MP 
group is provided by analysis of renal clearance data (Table 6). In 
the 5 pairs of animals given exogenous creatinine, mean plasma creatinine 
was less and total creatinine excretion was greater in the methylpred- 
nisolone-treated group; these changes were not statistically significant 
because of the great variability in the MP group. Urinary clearance of 
both creatinine and PYP was greater in the MP group, but again fell 
short of statistical significance. Interestingly, mean creatinine clear- 
c c 
ance ( Creatinine) and mean PYP clearance ( PYP), in ml/minute, were 
equivalent by paired t test analysis in both control and MP groups 
(Table 6). Linear regression analysis reveals a direct correlation 
c 
between ^PYP and ^Creatinine, with r=0.95 (Figure 9)- This suggests 
C 
that PYPis excreted by a pure glomerular mechanism, and that PYP is, 
Q 
like Creatinine, an indicator of glomerular filtration rate. This 
Q 
finding is used to good advantage in Table J, where PYP and urine PYP 
excretion are presented for all animals in which urine output was mon¬ 
itored. Note that one MP dog (8) was eliminated because of urinary 
leakj.around the catheter. PYP was significantly greater by group t 
test in the MP group than control, l63.^+ 25.7 vs. lll.lj^lS.^ ml/minute, 
p<0.05. Fractional excretion of PYP, PYP/ Creatinine, an indicator of 
renal tubular function, did not differ between the two groups of 5 dogs 
for which this supplementary information is available (Table 6). These 
data strongly indicate an increase in glomerular filtration rate 2h 
hours after administration of a single, massive dose of methylpredniso - 
lone. The result is that urine PYP excretion was greater in MP animals 
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^Creatinine ^PYP “^PYP 
(mg/100 ml) (mg) (ml/min) (ml/min) Creatinine 
CONTROL 
13 6.21 305.8 82.1 81.5 0.99 
IJ4 6.k9 318.5 81.8 113.0 1.38 
15 6.61 3T3.0 94.0 119.5 1.2T 
16 4.16 288.0 115.5 118.6 1.03 
IT 6.29 332.1 88.0 113. T 1.29 
Mean 5.95 323.5 92.3* 109.3* 1.19 
SEM 0.45 i4.3 6.2 T.l O.OT 
METHYLPREDNISOLONE 
13 6.35 28T.4 T5.4 IIT.5 1.56 
lU 5.45 314.1 96.1 T2.3 0.T5 
15 4.92 1156.5 391.8 345.2 0.88 
16 3.90 289.0 123.5 109.9 0.89 
IT 4.95 442.2 148.9 2o4.4 1.3T 
Mean 5.11 49T.8 i6t.1** 169.9** 1.09 
SEM 0.4o i6t.i 5T.5 48.9 0.16 
NS NS NS NS NS 
* Difference in means NS by paired t test. 
Difference in means NS by paired t test. 
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TABLE T Urine Volume and 
99m^ 
c-PYP Clearance and Excretion 
Urine 
Volume 





dose/ 1 hour) 
CONTROL 
7* 17.1 76.2 26.7 
8 7.9 68.7 70.6 
9 8.7 52.2 27.7 
10* 18.5 118.0 31.2 
11* 13.9 217.0 27.6 
12 70.7 i73.6 70.9 
13 71.6 81.5 31.9 
l7 78.1 113.0 7o.O 
15 68.8 119.5 77.5 
l6 292.1 118.6 36.0 
IT 73.1 113.7 79.7 
Mean 62.8 111.1 35.8 
SEM 27.7 13.7 2.7 
METHYLPREDNISOLONE 
7* 23.9 210.8 62.0 
9 236.0 107.5 71.7 
10* 75.9 120.7 32.7 
11* 22.7 216.7 36.9 
12 381.0 131.8 79.6 
13 177.6 117.5 35.6 
l7 396.2 72.3 57.1 
15 797.0 375.2 58.5 
16 365.5 109.9 38.0 
17 711.5 2o7.7 60.6 
Mean 282.1 163.7 76.9 
SEM 76.0 25.7 3.6 
p<0.005 p<0.05 p<0.01 
* Pairs of animals with similar urine volume, utilized in 
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than control, U6.9ji 3.6 vs. 35.8ji injected dose in one hour, p<0.01 
(Table 7). 
graphically 
These changes in PYP clearance and excretion are depicted 
in Figure 10. 
-29- 
.Oyc , sno rf.r h?d-2s(nJ: ^4.g_+8.?F . cv ^/iBifd" 
--.'ri^ no r./r^roxs Jin,B sr-wxeipr'.-) TV*^ n.r GosoRffo «S3ffT .(T sI'CbT) 
,' ■1 rti YXL'oj:!{qfi'i;j| 
DISCUSSION 
Effects of Methylprednisolone on Countershock Injury 
Myocardial ^^™Tc-PYP uptake 2h hours folio-wing transthoracic DC 
countershock correlated well with tissue CPK depletion (Figure 2). 
Myocardial CPK levels are presumed to Indicate the degree of cell-ular 
injury. In experimental myocardial infarction produced by coronary 
occlusion in rabbits, there is a linear relationship between regional 
myocardial blood flow and CPK depletion (120). Quantitative comparisons 
between tissue CPK concentration and the histologic extent of necrosis 
are difficult to make. Most attempts to quantify myocardial necrosis 
histologically have depended largely on the weight or area of tissue 
showing gross or microscopic evidence of necrosis (19? lOU, 106, 120). 
A semiquantitative histologic grading of myocardial biopsies was used in 
the current study. However, the biopsies examined showed necrosis of 
of such similar extent that it was not possible to distinguish among 
them s-ufficiently to permit quantitative correlation with either 
tissue CPK or ^^™Tc-PYP levels. Nevertheless, it is felt that myocardial 
CPK concentration is a meaningful reflection of the extent of tissue 
injury. The demonstration of a good correlation between tissue CPK 
depletion and ^^™Tc-PYP accumulation 2k hours after countershock was 
expected because this injury is kno-wn to spare blood flow (2l), and 
is the basis for using PYP tissue uptake in a quantitative way to 
assess myocardial necrosis after countershock. 
Dogs treated with a massive dose of methylprednisolone 90 minutes 
before two ^00 watt-second DC countershocks had a higher mean !^9“to-PYP 
sample:normal ratio than control, suggesting increased damage (Figure 3). 
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However, this was associated with reduced normal zone or background 
myocardial PYP levels, rather than an expected increase in abnormal 
zone uptake. Assessment of the extent of myocardial injury by tissue 
CPK depletion, precordial ST segment mapping and histologic grading pro¬ 
vided additional evidence that methylprednisolone did not modify counter¬ 
shock damage. 
Absolute normal zone PYP activity was significantly less in the MP 
group than control. This could reflect alterations in any factor capable 
of lowering circulating PYP, the most likely possibilities being increased 
bone uptake or increased urinary excretion. One may postulate that accum¬ 
ulation of PYP by necrotic myocardium occurs rapidly after injection 
of tracer. If most PYP uptake occurs during the first minutes after 
injection, before blood levels have been affected by different rates 
of bone uptake or urinary excretion, then abnormal zone PYP uptake 
would not be altered by changes in radionuclide kinetics. In this context 
it is worth considering that the major portion of myocardial uptake of 
potassium-US and thallium-201, radioactive cations which accumulate in 
normal tissue and leave infarcted tissue as a filling defect or a "cold 
spot", does occur during the first minute after injection (l2l). 
Radionuclide image detection depends on relative activity differ¬ 
ences between regions of increased or decreased uptake and background. 
This is the rationale behind expressing tissue radionuclide uptake in 
terms of a sample:normal ratio. In addition, variability in absolute 
abnormal zone count rates is reduced by normalizing to background or 
normal zone activity. The data presented are instructive, however, in 
that by reducing normal zone PYP activity, methylprednisolone treatment 
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unreliable as an expression of abnormal zone radionuclide uptake. 
Tissue CPK assessment of countershock damage was limited to 5 
control and U MP dogs because of the previously demonstrated correlation 
between CPK depletion and PYP uptake (Figure 2). The available data re¬ 
veal no difference between the two groups (Figure 5). Mean absolute nor¬ 
mal zone CPK levels were similar in control and MP animals, with a 
fair amount of inherent variability. Thus, the CPK sample:normal ratio 
was a valid expression of tissue enzyme activity. 
Precordial ST segment mapping revealed no difference in ^ST or 
NST between the -two groups at 0, 5 or 60 minutes (Figure 6). :^ST is 
considered to Indicate the severity of myocardial damage, while NST 
reflects the area of Injury (25). Several animals in both groups with 
sizable abnormal zones had minimal or absent ST elevation, indicating 
that ST segment analysis is an Insensitive indicator of myocardial damage 
in the countershock model. Correlation of ST segment data with PYP data 
was poor, with the best correlation, r= 0.40, obtained by comparing £ST 
at 5 minutes and the PYP samplernormal ratio. ST segment mapping was 
not a dependable means of quantifying myocardial injury in this model, 
even after eliminating animals without substantial ST elevations. In 
contrast to our results, Dahl et al. were able to show an excellent 
correlation (r= O.89) between mean ST segment elevation, obtained by 
means of a 25 lead precordial grid, and a "myocardial damage index", 
derived from gross area and microscopic severity of necrosis, in h2 
dogs after ten transthoracic countershocks (l9)- They also showed that 
ST elevation Increased as the size of paddle electrodes and the time 
Interval between shocks decreased. These authors do not report the length 
of time between termination of the discharges and ST mapping. More 
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importantly, they report that l6 animals had myocardial necrosis without 
ST elevation. Inclusion of these l6 animals in linear regression analysis 
would presumably have yielded a less impressive correlation between ST 
segment elevation and the "myocardial damage index". 
Epicardial (19) and precordial (81,122) ST segment mapping have 
been demonstrated to be a useful quantitative means of evaluating 
myocardial ischemic injury and its pharmacologic and hemodynamic modif¬ 
ication. However, recent reviews have emphasized a number of limitations, 
particularly in the clinical setting (123-125). ST segment changes result 
from electrical interactions between normal and abnormal tissue, and may 
be altered by factors modifying membrane potentials in either area (125). 
Precordial ST segment mapping, in particular, is limited by the electrical 
resistance of the chest wall and by the distance and three-dimensional 
geometry of the zone of injury (l25). Characterization of countershock- 
produced myocardial damage by precordial ST segment analysis is limited 
by these factors, with the additional geometric problem of two distinct 
zones of injury on opposite sides of the heart. 
The evidence presented Indicates that corticosteroid pretreatment 
failed to modify countershock Injury. Potential explanations might be: 
a) that corticosteroid as administered in these studies does not reduce 
myocardial cell death; b) that the electrical energy applied was too 
great to permit salvage of myocardium; and/or c) that countershock 
necrosis differs from ischemic necrosis in some way affecting potential 
for tissue salvage. 
None of the several mechanisms by which corticosteroids are be¬ 
lieved to modify myocardial injury is beyond reasonable doubt, as 
discussed in the review of the literature. Steroids certainly stabilize 
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lysosomal membranes vitro, but may not ^ vivo. There is no 
evidence that the anti-inflammatory effects of corticosteroids reduce 
myocardial cell destruction. The hemodynamic and metabolic effects 
of corticosteroids have been studied intensively, without proof of long 
term benefit, i..e., reduced infarct size. Corticosteroids appear to 
increase coronary blood flow, an effect of obvious importance to the is¬ 
chemic myocardium. Coronary blood flow was not measured in oiir exper¬ 
iments. Regional myocardial blood flow 2h hours after countershock is 
normal- l.e., there is no ischemic zone (2l). Even in the absence of 
an "ischemic stimulus" (73), it is possible that methylprednisolone 
treatment did increase myocardial blood flow. If so, there would have 
been increased delivery of ^^™Tc-PYP to hearts of MP animals, and one 
would have expected greater myocardial radionuclide uptake in the MP 
group. In fact, abnormal zone PYP uptake was not significantly different 
in the two groups, and normal zone PYP activity was clearly less in 
MP dogs than control. This indicates that if coronary blood flow had 
not been increased by methylprednisolone, then myocardial PYP uptake 
might have been even less in the MP group. In other words, augmented 
coronary blood flow, if present, opposed and minimized the effect noted. 
Maihtenance of regional myocardial blood flow is not the only dif¬ 
ference between countershock injury and ischemic injury. Myocardial 
infarction is not a sudden, all or none event. Jennings et al. showed 
that after coronary occlusion in the dog, the first irreversibly damaged 
cells appear at 22 minutes post-occlusion, and that even after minutes, 
35-^6^ of the cells remain viable {2h). The fact that all Ischemic cells 
do not die is the obvious basis for measures aimed at salvaging rever¬ 
sibly injured myocardiiun, as previously discussed. Evidence of early. 
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reversible cellular injury is noted by electron microscopy after 5 to 
15 minutes of actite experimental ischemia, and by light microscopy 
after 20 to 30 minutes. A number of morphologic and metabolic stages of 
early cellular injury are described (86, 87, 126) There is no sharp 
line dividing reversible from irreversible injury. Recent studies by 
Jennings’ group indicate that after UO minutes of experimental myocardial 
ischemia, there is loss of plasma membrane integrity, with inability to 
maintain intracellular voliime and electrolyte composition (12T), assoc¬ 
iated morphologically with cell swelling, muscle fiber contraction bands, 
and formation of amorphous densities in mitochondria staining positively 
for calcium (l28), and associated metabolically with defective mitochon¬ 
drial respiratory function (129). Such changes are not noted after 15 
minutes of ischemia, and are felt to indicate irreversible damage. 
Certain non-ischemic cellular injuries may result from direct attack 
on the cell membrane, causing rapid cell death and lysis (126). Anti¬ 
body and complement, ultraviolet radiation and direct mechanical injury 
may destroy cells in this manner. Such agents might exert their cyto¬ 
toxic effects in a rapid, all or none fashion. If DC countershock acts 
in like manner to produce myocardial necrosis, then its effects may not 
be modifiable by the subtle benefits ofcorticosteroid Intervention. Per¬ 
haps, also, the electrical energy applied was too great to permit signi¬ 
ficant modification of damage; lesser energies might conceivably have 
left more salvageable myocardium. 
Tedeschi and White initially described the areas of cardiac necrosis 
produced by epicardially applied countershock as "burns", and identified 
characteristic vascular engorgement, hemorrhage and edema, and "regressive" 
changes in muscle fibers (16). Anderson et al.found that the temperature 
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of countershock lesions, measured ■with thermistor prohes, was normal, 
suggesting that the damage was electrical, not a true burn (l7). They 
also described the following sequence of histological changes post-coun- 
tershock: immediately, loss of cytoplasmic organization, transverse 
handing in myofibrils, interstitial edema without cellular reaction; at 
3 days, interstitial infiltrate composed of endothelial cells, macro¬ 
phages, fibroblasts and very few polymorphonuclear leukocytes; at 1 
week, increased cellular reaction; from 2 to U weeks, disappearance of 
cellular reaction, increasing fibrosis... The lesions as described differ 
from ischemic coagulation necrosis in two important ways: l) immediate, 
cytoplasmic changes; and 2) few polymorphonuclear leukocytes (iT). 
The virtual absence of polys and predominence of mononuclear cells and 
fibroblasts has been confirmed in transthoracic countershock (l8, 20). 
Reichenbach and Benditt believe that the histologic changes 
associated with countershock fit into the pattern of myocardial injury 
kno-wn as ’’myofibrillar degeneration” (l30). This cardiac lesion occurs, 
as does countershock, in the presence of an intact microcirculation. 
It is reportedly a common autopsy finding in man, and accompanies various 
clinical and experimental situations. In particular, it is associated 
with catecholamine excess, both endogenous (pheochromocytoma in man) and 
exogenous (isoproterenol-induced cardiac injury in rabbits). It is 
postulated that myofibrillar degeneration is the result of a common 
pathogenic mechanism whereby catecholamines released locally by myo¬ 
cardial sympathetic nerve terminals or distantly by the adrenal glands 
increase cardiac work and oxygen requirements while uncoupling oxidative- 
phosphorylation and reducing available ATP, resulting in myocardial 
cellular necrosis (l30). 
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Davis et al. have looked again at the morphology of countershock- 
produced myocardial injury, and feel that it is, indeed, a form of 
myofibrillar degeneration (l8). After several weeks the fibrous scar 
of countershock-produced necrosis is indistinguishable from that of 
ischemic Infarction, but they appear to originate as distinctly different 
forms of injury. This could at least in part, explain different responses 
to corticosteroid pharmacologic intervention. In this context, it is in¬ 
teresting that Fleckenstein has reported that pretreatment with 9®<-flu.or- 
ocortlsol markedly Increases isoproterenol-induced myocardial necrosis 
and calcium uptake in rats (99)* This, then, is a situation in which 
corticosteroid exacerbates myofibrillar degeneration. 
Effects of Methylprednisolone on ^^^c-PYP Distribution and Excretion 
^he data presented suggest that reduced normal or background 
99in. 
myocardial Tc-pyrophosphate activity in methylprednisolone-treated 
dogs was related to reduced circulating PYP. It seems likely that 
what is measured in the scintillation counter as "uptake” of radionuclide 
by normal myocardium and other non-osseous tissues is actually extra¬ 
cellular radionuclide in capillary blood. As noted, presumed differences 
in Intravascular volume in the two groups, resulting from markedly 
different urine output after water loading, probably masked the expected 
difference in blood PYP activity. Even so, a trend was suggested where 
blood clearance of PYP was more rapid, l.e., PYP levels became less, in 
the methylprednisolone-treated group than control (Figure 8). Con¬ 
sidering only animals not water loaded, or with comparable urine output, 
blood PYP was significantly less in the MP group than control at the 
time of sacrifice (Table 3). 
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c-PYP activity was expressed here as absolute Blood 
counts per minute (CPM)/ml/mCi injected (Table 3) and not as a percentage 
of the injected dose because well-counter calibration - saving and count¬ 
ing fractions of a 1:1000 dilution of a 0.1 ml aliquot of the dose to per¬ 
mit calculation of CPM/mCi injected - was done only in the last 11 pairs 
of animals studied. The value for CPM/mCi varied somewhat from day to 
g 
day, perhaps due to well-counter voltage flirxes, averaging 6.31 x 10 
CPM/mCi (range: 5-3T to 8.19 x 10^ CPM/mCi). Thus, if 10 mCi of ^^^c- 
PYP were administered to all animals, then the approximate average dose 
. 9 
would be 6.31 x 10 CPM. For each time of injection, expression of 
blood PYP activity (in CPM/ml/mCi) as a percentage of the approximate 
total dose Injected (6.31 x 10^ CPM/ 10 mCi), times 1000, gives an estim¬ 
ation of the mean % injected dose per liter of whole blood (Table 3). 
Assuming that total blood volume in the dog approximates 7*5^ of body 
weight in liters, and using the mean body weights for the two groups 
of dogs given in Table 5? these data can be converted to mean % injected 
dose per total blood volume (Table 3). It thus is estimated that in the 
control group, h.h% dose/liter whole blood (or 6.3% dose/ total blood 
volume) circulated at 60 minutes after injection. In the methylprednls- 
olone group, the values are somewhat lower - 3.5^ dose/L (or 5.1^ dose/ 
total blood volume). Considering, as before, animals not water loaded 
or with similar urine volume, the estimated values become: control, 
5.2^ dose/L ( or 1 .’3% dose/total blood volume), and methylprednisolone, 
3.3^ dose/L {or k.Q% dose/total blood volume). 
These approximations compare well with those of others who. have 
studied blood clearance of ^^™Tc-PYP. At one hour, Hosain measured about 
'3% of the Injected dose in the total blood volume of 5 dogs (l3l). Krlsh- 
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namurtliy et al. found 2.9^ dose/L whole blood in 10 patients at one 
hoTir^(.133Snbramanian et al. reported 13.0^ dose/total blood vol\me 
at one hour in 6 patients (l32), which, assuming 70 kg and a total blood 
volume of body weight in liters, converts to 2.7^ dose/L. 
In our experiments, binding of ^^^c-PYP to plasma proteins did 
not differ in the two small groups studied. A reduction in plasma 
protein-binding in the methylprednlsolone group could have accounted 
for more rapid urinary excretion secondary to increased filtered load. 
Protein-bound PYP represented 77*5^ of plasma activity in the control 
group and 78.8^ of plasm\ activity in the MP group (figure 9)- Others 
have reported the percentage of plasma protein-bound PYP at one hour 
after injection to be 84.3^ in the dog (133), and 4-5.4^ (l32) and from 
10-69^ (135) in man. ^^™Tc -PYP binds loosely, and mainly to the globulin 
fraction (l33). 
Bone PYP uptake was also similar in the two groups of dogs, aver¬ 
aging .018^ dose/gm in the control group and .017^ dose/gm in the MP 
group (Table 5). ^^™Tc-PYP is a bone-seeking radionuclide, and bone 
is the body's principal PYP reservoir (131-133). Thus, increased 
bone PYP uptake in the methylprednlsolone group could have accounted for 
reduced circulating PYP and reduced normal myocardial PYP. Bone PYP 
count density in our studies approximates that reported by Bonte et al. 
in early experiments (136, 137)* Eckelman et al. found PYP uptake of 
.006^ dose/gm in dog femur (138). We have noted considerable variation 
in percentage uptake of PYP dose by rib, iliac crest and femur in 
individual animals, a fact observed by others using a number of skeletal 
imaging agents (l32). 
Myocardial PYP accumulation was less in the methylprednisolone- 
-39- 
ar.o B.'h • Cl rr'' FxjoX'f S'/.c.r''v 
'’■ ■■■• • oc:■!/'' X.:' vy,C.^X 
^ X /T; ;:V 'nrxLrscG 
. "rNX'’,'! voX pX'■■ ■’.'■'■■''i,*;' p*!: 
'X ' Xoxcr ,B. XX C ■ ox ' ;ji/o 
- ;x rirX o o;'- -A ..C&.rx -J 
;. •, • o->o c Vi.xf bisjx -j .'x^. ^ . 'r, ",■ 
•■ rv- xJx?: X ‘^rfri oX ■. 
'XXi'i'O'' eC" .■•■/ ‘''’X e‘'X.. !'i ■ ‘ ' 
. '■'■X.! X'' ,' 'rwO'.;, •' 
X • -r - ■ ■ ' It. a '■ ' 
'• X'- I' ' X' X .-;x b::r . ' ; : 
'-j Oo ".rr;.’xm /. '•■: ■ ‘ ■ ■ ■oL :;. 
• • coixi'r;- .y 7* :-j 
■ X‘ ■ , 'c :• ; i ±'' . I'T xr/i 
' • i: Xx 7 'O Hj-TT - f-'- ’’c.;.:- 
-■ —X- .-yf: . • - 1) 
ty r ,,,.,. ...-,- ' r,,QQ -ircxr- 'xo, 
'-O ‘X' x- ' fr xii'xjPOO'-' ' " r»r 
■ • X '-x-x 
- i .'^o - . •.. •'"6* fT.rrj ^ * 
rsr xrr JpldX-. •: . X;;, xoo 7. 
x .r.n,r J'Br'.ro o,-:f;.Cx. . X: 
.r.‘.1' ■ X' ''.V ',T "■ .• •f'’"-'’)' '.'Xi+c "7 b 
-rOx-.':. xffI o'^■ ■',■'■=:!” yjfXd" nl c'f"'-r t-,-,;:' 
..OV'm 
ilXer C ■ .7 •j.iirxra': .Xx; d‘9 Yf!d''it'ro"rf 
J:cX':fr '■ .:j: sno ,+g 
X ‘ X ' ' bo rr'TJLr.COV 
f'XXr.X: ' , 7.b r-' -• -*r5^rrj.;r, -fj/r) 
O'l;; .r X?) r:*; nX "f- 
■:c.DvjASx;'^ --rrx 7:-Xf'.xrx.x..-v,r'boxq 
no-f.-'o': ■or)-- ■■ TGnX'Xtr >j r ■-.■ •■ ' 'xo'f 
. TT y'S •' '/■Sox' ■ •OX xr: or^-n Ao‘s:-l 
-XxvXJx - Ix: ‘;o X'- .'"Y hc.C'. qX'OT' 
r,;. ••*,; ^v/fr 
ft't' r* ' 
^ r 
9 £ ox*' .bo XX0 X.X bodrXy 
; - - n * . rr.tjjTr n.,: •' bX) x^-r-OI 
-fX' . ■ 
L'" osl ,i> r-. p,* ; ■: Xo.'^ r ' XY"’ v.ioY 
iior '■'lO. rrnrvx. 
-Y" —.-rv :rC- ■ ■ ui.-- J irfi’- ■■’: v 
X-y-''- ' ' JXPcrxr .J,-': r ‘ ?, x 
b-aby:;-;,.' 'VX' --norf 
-Y i ■. y’'.j'J', r.tX.'r {• ••.■ l.’bf ''C 
"yCT- ty ”-frr. rrX r’-'-CQO ■ 
<-X - X' • .Y;o/irX'r7qx!? /rr 
.iy.''-X; ‘liffl'f'f • '.e'er '“'Xb'O 
f s eoL ".A" o 'v; Jf.oo'r!: q ni: 
'o r. v !•> 
'■ fir. x;' ^ X; 'i';!. 0 0£ ' X'' £ « i tiii o 
W;'| 
.00118^ dose/gm in the treated group, averaging .00079^ dose/gm vs. 
control group. Bonte et al. found normal myocardial PYP activity at 
one hour to average .00077^ dose/gm (136) and .0028^ dose/gm (l37) in 
separate experiments with small numbers of dogs. 
Kinetic studies by Krishnamurthy et al. have indicated that clear¬ 
ance of ^^™Tc-PYP from the blood occurs biexponent!ally with the first 
phase thought to represent bone uptake and having a half-life 
13.6 minutes, and the second phase believed to indicate renal clearance 
and having a over 6 hours (l33). Their data indicated that by 
one hour, in man, l6.U^ of the injected PYP dose was excreted in the 
urine. Others have reported higher values for one hour urine PYP excre¬ 
tion amounting to 15-35^ dose (l35) and 29.9% dose (l32) in man, and 
nearly 35^ dose in the dog (l3l). Our control dogs had a mean one hour 
urine PYP excretion of 35.8^ of the injected dose, compared with a sig¬ 
nificantly greater PYP excretion of hG.9% dose in methylprednisolone- 
treated animals (Table 7). This represents a 31^ increase in one hour 
urinary PYP excretion occurring 2h hours after massive, single dose 
methylprednisolone treatment. It appears to be sufficient to explain 
reduced blood and background myocardial PYP levels in these animals. 
Further analysis of data reveals the mechanism by which methylprednlsolone 
treatment increased urinary PYP excretion. 
The demonstration of a close correlation between clearance of PYP 
and creatinine clearance in 10 dogs (Figure 9) suggests that, like inulin 
and creatinine in the dog, PYP is excreted by a pure glomerular mechanism. 
PYP clearance was significantly greater in the methylprednisolone-treated 
group than control (Table 7). Fractional excretion of PYP, an index of 
renal tubular function, was the same in both groups. These findings 
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indicate an increase in glomerular filtration rate 2k hours after 
administration of a single large dose of methylprednisolone. 
There are a number of precedents for an increase in GFR after several 
days of adrenocorticotropic hormone (ACTH) or corticosteroid adminis¬ 
tration to small groups of patients with normal or impaired renal function 
(139-1^2). In studies by Levitt and Bader in 6 patients, inulih clear¬ 
ance increased an average of 31^ progressively during ACTH or cortisone 
administration over a week or more (l42). Patients reported by Alexander 
et al. had increments in inulin clearance as great as 103^ and 86% after 
ACTH treatment for 8 and l4 days, respectively (lUl). Chronic adminis¬ 
tration of ACTH or cortisone to four dogs increased creatinine clearance, 
twice after only one dose (l43). Acute administration of dexamethasone, 
8-10 mg TV, to four dogs had an immediate effect of CFR, which Increased 
a mean of 29% (range 5-45^) by one hour (l44). This effect of cortico¬ 
steroids was in one study (l42) clearly associated with expansion of 
extracellular fluid volume, but in others (l43,l44), it appeared to 
occur independently. Methylprednisolone, which has little or no mineral- 
ocorticoid effect (l45), has been shown to increase inulin clearance in 
the dog (l46) and in the rat (l47) with chronic administration. The 
mechanism by which glucocorticoids increase CFR is not entirely clear, 
but several studies have demonstrated an associated increase in renal 
plasma flow (139, l40, l43, l47). DeBermudez and Hayslett showed with 
redioactive microspheres that the 42^ increase in renal plasma flow after 
methylprednisolone administration in rats occurred predomlnently in the 
inner cortex, where nephrons with long loops of Henle may play a special 
role in sodium reabsorption (l47'). The redistribution of renal blood 
flow to the inner cortex may not explain the Increase in glomerular 
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filtration rate, but it would provide a means of maintaining sodium 
balance through increased tubular reabsorption in the face of an increased 
filtered load. 
Changes in the urinary excretion of a variety of substances occur 
following the administration of ACTH or cortisone. After several days 
of such therapy in patients, there may be increased urinary excretion of 
potassium (lU8), uric acid (139? lU8) and phosphate (l^O, 1^8), and 
decreased urinary excretion of sodium (l^l, lU8). These effects appear 
to reflect alterations in renal tubular transport of filtered substances 
(l48). In our studies, renal tubular handling of ^^™Tc-PYP appeared to 
be unchanged, supporting a primary effect of methylprednisolone on glom¬ 
erular filtration rate. 
An incidental observation in the present study is the massive 
increase in urine volume in the MP group. Several reports confirm an 
increase in free water clearance after corticosteroid treatment (l43, lU6, 
1^7, 1^9)- Patients with adrenal Insufficiency and adrenalectomized or 
hypophysectomlzed animals exhibit impaired free water excretion which is 
corrected by corticosteroid replacement. Corticosteroids may inhibit 
the back diffusion of water in the renal tubular diluting segment or 
collecting duct (1U9). 
The result of increased glomerular filtration rate in the methyl- 
prednisolone-treated group was more rapid urinary excretion of PYP, caus¬ 
ing lowered blood PYP levels. Since tissue PYP levels appear to reflect 
blood PYP levels, normal myocardial PYP activity was lower in the IIP 
group than control. It is clear that altered radionuclide kinetics may 
significantly modify assessment of myocardial injury. This finding is 
of importance clinically as well as experimentally. Recently, a niimber 
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myocardial infarct images have of cases of diffusely positive ^^™Tc-PYP 
been reported in patients because of delayed removal of radionuclide from 
the blood pool (l50, 15l)- Canine gracilis muscle uptake of potassium-U3 
and thallium-201 is altered by propanolol and isoproterenol treatment, 
suggesting that myocardial uptake of these radionuclides might also be 
changed by commonly employed drug therapy (l2l). The present experiments 
confirm that if myocardial radionuclide uptake is to be used to identify 
myocardial necrosis and to assess its possible modification,then the in¬ 
trinsic effects of any intervention or other circumstances must be defined 
to avoid misinterpretation. 
Conclusions 
Although methylprednisolone-treated dogs had a higher mean ^^^c-PYP 
sample:normal ratio, suggesting Increased damage over control, this was 
a result of reduced normal or background myocardial PYP levels. There 
was no true difference in tissue damage, as assessed by absolute abnormal 
zone PYP activity, by CPK depletion, by ST segment mapping, and by histo¬ 
pathologic grading. 
Potential explanations for the failure of corticosteroid pretreat¬ 
ment to modify countershock injury have been discussed. It is suggested 
that myocardial necrosis after countershock resembles "myofibrillar 
degeneration", a lesion distinctly different from ischemic coagulation 
necrosis. Alternatively, administration of corticosteroids in different 
dosage or at a different time, or use of lower energy countershock, 
might have permitted tissue protection. 
Reduced normal or background myocardial ^^c-PYP in methylprednis¬ 
olone-treated animals appears to reflect reduced circulating PYP. PYP 
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distribution studies revealed no difference in plasma protein binding or 
in bone uptake of PYP. Urinary clearance of PYP, shown to correlate well 
with creatinine clearance, was significantly greater in the MP group 
than control. This suggests an increase in glomerular filtration rate 
after corticosteroid administration, a finding supported by a number of 
previous studies. As a result, urinary PYP excretion was increased in 
MP animals, explaining reduced normal myocardial PYP levels. It is 
concluded that altered radionuclide kinetics may result in incorrect 
assessment of myocardial injury. 
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k. In 
SUMMARY 
After a review of pertinent literature, experiments have been de¬ 
scribed which demonstrate that myocardium damaged by DC countershock 
in dogs accumulates ^^™Tc-pyrophosphate in proportion to the extent 
of CPK depletion. Pretreatment with methylprednisolone, a cortico¬ 
steroid, produced no demonstrable difference in tissue damage, as 
assessed by abnormal zone ^^™Tc-pyrophosphate uptake, by tissue CPK de¬ 
pletion, by precordial ST segment mapping, and by histologic and 
histochemical examination. However, methylprednisolone administration 
did alter the radionuclide assessment of myocardial necrosisj creating the 
initial impression of increased tissue damage. Radionuclide distribution 
and excretion studies indicated that methylprednisolone increased 
glomerular filtration rate, resulting in accelerated renal excretion of 
^^^c-pyrophosphate. To avoid misinterpretation in the use of myo¬ 
cardial radionuclide uptake in assessing myocardial necrosis, the 
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1. Representative myocardial scan showing two zones of increased 
^^TC“pyrophosphate uptake (a.). After elimination of background 
activity, abnormal zone was divided by itself to obtain a unity 
image (b.). Computerized data processing permitted expression of 
abnormal activity as count density. See text for explanation. 
2. Tc-pyrophosphate (PYP) uptake vs. creatine phosphokinase 
(CPK) depletion, expressed as sample:normal fS:]!) ratios, for 
50 transmural myocardial samples from areas of countershock Injury 
in three control dogs. 
3. Myocardial -PYP tissue uptake in control (C) and methyl- 
prednisolone (MP) groups: at left, mean sample:normial ratios; 
center, mean absolute abnormal zone activity; right, mean absolute 
normal zone activity. Statistical analysis by group t test. 
NS = not significant. 
h. Abnormal zone size, as assessed by ^^^c-PYP uptake: at left, 
mean STommed weights of all tissue samples with S:N ratios greater 
than 3:1; at right, mean radionuclide count density as measured 
by quantitative imaging as described in text. 
5. Myocardial CPK activity in control (C) and methylprednlsolone (MP) 
groups: at left, mean sample:normal ratios; center, mean absolute 
abnormal zone CPK; at right, mean absolute normal zone CPK. All 
comparisons not significant (NS). 
6. Precordial ST segment mapping: mean £ST and NST for 1^ control 
and 12 methylprednlsolone treated dogs before (O) and 5 and 60 minutes 
after countershocks. All comparisons NS. 
T. Histopathology: a, mean histopathologic grades for 13 biopsies 
from 8 dogs in each group; b, representative low power (125X) 
hematoxylin and eosin stained photomicrograph demonstrating fragmenta- 
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tion of muscle fibers, interstitial edema, and mixed leiikocyte 
reaction; c, subepicardial zone of damaged myocardiiam accumulating 
Masson stain; d, high power (5OOX) hematoxylin and eosin stained 
section showing obvious myocardial fiber destruction, transverse 
banding, and cellular reaction, with mononuclear leuhocytes predom¬ 
inating over polymorphonuclear cells. 
8. ^^™Tc-PYP blood clearance curves for control (C) and methyl- 
prednisolone (MP) groups. Differences in mean activity at each 
time after injection of dose are NS, except when animals not water- 
loaded or with similar urine output are compared (*). Difference 
between means for these 9 C and 9 MP dogs is significant, p< 0.025. 
See text for explanation. 
9. ^^™Tc-PYP clearance vs. creatinine clearance in 5 control (C) and 
5 methylprednisolone (MP) dogs. Bemonstration of a direct correlation 
suggests that PYP depends largely on glomerular filtration for urinary 
excretion. 
(left) and one hour urinary excretion 10. 
(right) in C and MP groups. Both means are significantly less in the 
methylprednisolone treated group. 
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